About Sebastian Bernales
Form D filings for Metagenomi Technologies from 2020 to 2024 list Sebastian Bernales as director.
Sebastian Bernales reports to the SEC as a director of 1 public company: Metagenomi Therapeutics (MGX).
Sebastian Bernales first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Sebastian Bernales in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sebastian Bernales works with at each company, as listed on that company's latest Form D.
Metagenomi Technologies, LLC · Form D, Jan 11, 2023
WD
Willard Dere
Director
BT
Brian Thomas
Chief Executive Officer and director
SP
Santhosh Palani
Director
RS
Risa Stack
Director
JE
Juergen Eckhardt
Director